Latest California Healthline Stories
Pricey Precision Medicine Often Financially Toxic For Cancer Patients
Medical treatments targeting the DNA in tumor cells are celebrated, but insurers often won’t cover the skyrocketing cost.
Must Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Facebook Live: The Cancer Divide
Californians and Americans are living longer with cancer — but some are living longer than others. California Healthline’s Facebook Live addresses disparities in cancer diagnosis, treatment and care — and what can be done about them.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
Readers And Tweeters Slice And Dice Precision Medicine, Step Therapy
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Much Touted For Cancer, ‘Precision Medicine’ Often Misses The Target
Doctors and hospitals love to talk about the patients they’ve saved with precision medicine, and reporters love to write about them. But the people who die still vastly outnumber the rare successes.
Doctor To The Stars Disciplined Over Use Of Controversial Menopause Therapy
Dr. Prudence Hall has made a name for herself in the field of “bioidentical hormones” — plant-based compounds purportedly customized for each patient’s needs. Experts say the popular approach is unproven; California regulators say she was grossly negligent in her care of two patients.
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health articles from the week so you don’t have to.
For Nursing Home Patients, Breast Cancer Surgery May Do More Harm Than Good
A new study of 6,000 older patients shows little gain from surgeries for breast cancer.
Listen: Cancer Survival Rates Up Among Californians
Overall, Californians are beating cancer for longer due to earlier detection and better treatment of the disease, a new study reveals. But the gains are not felt equally: Whites fare better than blacks, and younger patients better than older.